0000904454-23-000482.txt : 20230811 0000904454-23-000482.hdr.sgml : 20230811 20230811100250 ACCESSION NUMBER: 0000904454-23-000482 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230811 DATE AS OF CHANGE: 20230811 EFFECTIVENESS DATE: 20230811 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Finepoint Capital LP CENTRAL INDEX KEY: 0001608126 IRS NUMBER: 462183973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16580 FILM NUMBER: 231161955 BUSINESS ADDRESS: STREET 1: 500 BOYLSTON STREET STREET 2: 24TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: (617) 336-2200 MAIL ADDRESS: STREET 1: 500 BOYLSTON STREET STREET 2: 24TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE false false false 0001608126 XXXXXXXX 06-30-2023 06-30-2023 false Finepoint Capital LP

500 Boylston Street 24th Floor Boston MA 02116

13F HOLDINGS REPORT 028-16580 000170668 801-79330 N Stacy L. Vezina 617-336-2212 Stacy L. Vezina Boston MA 08-11-2023 0 37 289062399 INFORMATION TABLE 2 infotable.xml ACADIA PHARMACEUTICALS INC COM 004225108 20284524 846953 SH SOLE 846953 0 0 AFTERNEXT HEALTHTECH ACQUISITION CORP *W EXP 99/99/999 G01109126 31753 366666 SH SOLE 366666 0 0 AMICUS THERAPEUTICS INC COM 03152W109 16651734 1325775 SH SOLE 1325775 0 0 APELLIS PHARMACEUTICALS INC COM 03753U106 22017959 241690 SH SOLE 241690 0 0 ARES ACQUISITION CORP *W EXP 02/02/202 G33032122 403765 504706 SH SOLE 504706 0 0 ARVINAS INC COM 04335A105 10213430 411500 SH SOLE 411500 0 0 ASCENDIS PHARMA A/S SPONSORED ADR 04351P101 12474651 139772 SH SOLE 139772 0 0 BAUSCH HEALTH COS INC COM 071734107 9320000 1165000 SH SOLE 1165000 0 0 BILANDER ACQUISITION CORP *W EXP 05/19/202 09001T114 9334 183749 SH SOLE 183749 0 0 BRIDGETOWN HOLDINGS LTD *W EXP 09/30/202 G1355U121 221960 895000 SH SOLE 895000 0 0 CEREVEL THERAPEUTICS HLDNG I COM 15678U128 15658006 492545 SH SOLE 492545 0 0 CHURCHILL CAPITAL CORP V *W EXP 10/29/202 17144T115 110221 612000 SH SOLE 612000 0 0 CHURCHILL CAPITAL CORP VI *W EXP 02/17/202 17143W119 97200 540000 SH SOLE 540000 0 0 CHURCHILL CAPITAL CORP VII *W EXP 02/29/202 17144M110 76720 548000 SH SOLE 548000 0 0 CLARIVATE PLC ORD SHS G21810109 11887779 1247406 SH SOLE 1247406 0 0 COMPASS DIGITAL ACQUISITION CORP *W EXP 09/29/202 G2476C123 68434 459906 SH SOLE 459906 0 0 CONCORD ACQUISITION CORP II *W EXP 99/99/999 20607U116 16333 408333 SH SOLE 408333 0 0 CONYERS PARK III ACQUISITION CORP *W EXP 08/12/202 21289P110 28583 571666 SH SOLE 571666 0 0 CORSAIR PARTNERING CORP *W EXP 07/06/202 G2540H116 0 334666 SH SOLE 334666 0 0 CRINETICS PHARMACEUTICALS IN COM 22663K107 14371437 797527 SH SOLE 797527 0 0 CYTOKINETICS INC COM NEW 23282W605 12039814 369093 SH SOLE 369093 0 0 FIRST LIGHT ACQUISITION GROUP INC *W EXP 03/14/202 320703119 85176 655200 SH SOLE 655200 0 0 GALAPAGOS NV SPON ADR 36315X101 16542887 406859 SH SOLE 406859 0 0 HOME PLATE ACQUISITION CORP *W EXP 09/30/202 43734R111 14697 690000 SH SOLE 690000 0 0 MARBLEGATE ACQUISITION CORP *W EXP 08/31/202 56608A113 41307 735000 SH SOLE 735000 0 0 MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD 61559X104 15402000 302000 SH SOLE 302000 0 0 MORPHIC HOLDING INC COM 61775R105 16485585 287556 SH SOLE 287556 0 0 PROTHENA CORP PLC SHS G72800108 21665244 317300 SH SOLE 317300 0 0 RELAY THERAPEUTICS INC COM 75943R102 8811719 701570 SH SOLE 701570 0 0 ROSS ACQUISITION CORP II *W EXP 02/01/202 G7641C114 74435 439666 SH SOLE 439666 0 0 SAGE THERAPEUTICS INC COM 78667J108 16822110 357765 SH SOLE 357765 0 0 SAREPTA THERAPEUTICS INC COM 803607100 14367336 125457 SH SOLE 125457 0 0 SOLID BIOSCIENCES INC COM NEW 83422E204 5036955 961251 SH SOLE 961251 0 0 SPRINGWORKS THERAPEUTICS INC COM 85205L107 15958226 608628 SH SOLE 608628 0 0 SWIFTMERGE ACQUISITION CORP *W EXP 12/13/202 G63836111 48020 490000 SH SOLE 490000 0 0 TRAVERE THERAPEUTICS INC COM 89422G107 11700035 761721 SH SOLE 761721 0 0 YS BIOPHARMA CO LTD *W EXP 03/15/202 G9845F117 23030 489999 SH SOLE 489999 0 0